{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:47:57Z","timestamp":1781920077276,"version":"3.54.5"},"reference-count":14,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamadermatol.2021.4083","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:27:58Z","timestamp":1636590478000},"page":"1472","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme"],"prefix":"10.1001","volume":"157","author":[{"given":"Camille","family":"Roux","sequence":"first","affiliation":[{"name":"Department of Dermatology, Henri Mondor Hospital, AP-HP, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sbidian","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henri Mondor Hospital, AP-HP, Cr\u00e9teil, France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil EpiDermE, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-David","family":"Bouaziz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Saint-Louis Hospital, AP-HP, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Kottler","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bichat Hospital, AP-HP, Universit\u00e9 de Paris, Paris, France"},{"name":"Department of Dermatology, Caen University Hospital, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Descamps","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bichat Hospital, AP-HP, Universit\u00e9 de Paris, Paris, France"},{"name":"Department of Dermatology, Caen University Hospital, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Prost","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Avicenne Hospital, AP-HP, Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Samimi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Seneschal","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Reference Center for Rare Skin Diseases, Universit\u00e9 Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dupin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cochin Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Girard","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Montpellier University Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Paul","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Est Cr\u00e9teil EpiDermE, Cr\u00e9teil, France"},{"name":"Department of Hospital Pharmacy, Henri Mondor Hospital, AP-HP, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Le Cleach","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henri Mondor Hospital, AP-HP, Cr\u00e9teil, France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil EpiDermE, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henri Mondor Hospital, AP-HP, Cr\u00e9teil, France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil EpiDermE, Cr\u00e9teil, France"},{"name":"Reference Center for toxic bullous dermatoses and severe drug reactions TOXIBUL, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"dbr210018r1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cden.2013.07.001","article-title":"Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment.","volume":"57","author":"Samim","year":"2013","journal-title":"Dent Clin North Am"},{"issue":"5","key":"dbr210018r2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/bjd.1993.128.issue-5","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients.","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"issue":"1","key":"dbr210018r3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007.","volume":"62","author":"Wetter","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"dbr210018r4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaad.2018.03.013","article-title":"Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme: a single-center series of 33 cases compared with 100 cases induced by other causes.","volume":"79","author":"Amode","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"dbr210018r5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"issue":"5","key":"dbr210018r6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jdv.2019.33.issue-5","article-title":"Interventions for erythema multiforme: a systematic review.","volume":"33","author":"de Risi-Pugliese","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"dbr210018r7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/(ISSN)1365-2133","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme.","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br J Dermatol"},{"issue":"6-7","key":"dbr210018r8","first-page":"375","article-title":"[Treatment by thalidomide of chronic multiforme erythema: its recurrent and continuous variants. a retrospective study of 26 patients].","volume":"123","author":"Cherouati","year":"1996","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"dbr210018r9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000249598","article-title":"Erythema multiforme\u2014response to corticosteroid.","volume":"169","author":"Ting","year":"1984","journal-title":"Dermatologica"},{"issue":"1","key":"dbr210018r10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"9423","key":"dbr210018r11","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide.","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"dbr210018r12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1046\/j.1523-1747.2002.19502.x","article-title":"Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.","volume":"119","author":"Bastuji-Garin","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"6","key":"dbr210018r13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/jnnp.31.6.543","article-title":"Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.","volume":"31","author":"Fullerton","year":"1968","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"dbr210018r14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/jamadermatol.2017.5889","article-title":"Lenalidomide as an alternative to thalidomide for treatment of recurrent erythema multiforme.","volume":"154","author":"Drahy","year":"2018","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2785842\/jamadermatology_roux_2021_br_210018_1639533875.90504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T16:08:28Z","timestamp":1639584508000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2785842"}},"subtitle":["A Multicenter Retrospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.4083","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}